Andrew Dudum
speaker
1,578 appearances
3 recordings
3 series
first heard Apr 2026
last heard 5 Jul
Andrew Dudum’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsRecordings per month over the last 12 months — 3 in all, peaking in Apr 2026 with 2.
Appearances
And so with these medicines particularly, the side effect rates were so high that that personalization dynamic was critical for patients.
And because of that, the business grew very quickly, extremely quickly, because patients wanted that personalization.
I mean, it was—
Now, what happened was, I think, phenomenal.
Not without friction, but phenomenal.
The drug companies reacted to two different things.
One, they reacted to the pricing pressure.
So we were able to manufacture and compound these vials, personalized for patients, and offer it to them for something like $150.
The price of the FDA-approved medication at the time was $1,500.
And so the pure exposure, the transparency of a model like him's and hers, where it says, hey, we're consumer-oriented.
We can make this stuff.
We have these facilities.
It costs us about, you know, 80 bucks all in with all of our stuff.
So we're going to put a markup on it.
We're going to sell it to you for 150.
And it was very transparent about how this all worked.
Resulted in immense pressure on the drug companies to take...
the blockbuster medicine of this century and bring its price down to what consumers could actually afford.
And through all types of regulatory pressure, through corporate pressure from us, through consumer pressure, those medications are now available to consumers for $150, the brand name medications.
That has never happened in the history of this country.
Showing 221–240 of 1,578 · page 12 of 79
← Previous
Next →